Maternal glucagon-like peptide-1 is positively associated with fetal growth in pregnancies complicated with obesity
Clinical Science · 26.04.2023 · 137 (8) · 663-678
DOI: 10.1042/cs20220890 ↗Kurz gefasst
Fachartikel in der Zeitschrift Clinical Science, online erschienen am 21.04.2023. Verfasst von Jerad H Dumolt und 5 weiteren Autor:innen. Beteiligte Einrichtung: Department of Obstetrics & Gynecology, Division of Reproductive Sciences, University of Colorado Anschutz Medical Campus, Aurora, CO, U.S.A. Hauptthemen laut MEDLINE: Diabetes, Gestational, Placenta. Die Arbeit wurde bisher 17-mal zitiert (Crossref) und nennt 70 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 2.0). Gefördert von: NICHD NIH HHS.
Abstract (Originalsprache)
Pregnant women with obesity are more likely to deliver infants who are large for gestational age (LGA). LGA is associated with increased perinatal morbidity and risk of developing metabolic disease later in life. However, the mechanisms underpinning fetal overgrowth remain to be fully established. Here, we identified maternal, placental, and fetal factors that are associated with fetal overgrowth in pregnant women with obesity. Maternal and umbilical cord plasma and placentas were collected from women with obesity delivering infants who were LGA (n=30) or appropriate for gestational age (AGA, n=21) at term. Maternal and umbilical cord plasma analytes were measured using multiplex sandwich assay and ELISA. Insulin/mechanistic target of rapamycin (mTOR) signaling activity was determined in placental homogenates. Amino acid transporter activity was measured in isolated syncytiotrophoblast microvillous membrane (MVM) and basal membrane (BM). Glucagon-like peptide-1 receptor (GLP-1R) protein expression and signaling were measured in cultured primary human trophoblast (PHT) cells. Maternal plasma glucagon-like peptide-1 (GLP-1) was higher in LGA pregnancies and positively correlated to birthweight. Umbilical cord plasma insulin, C-peptide, and GLP-1 were increased in obese-large for gestational age (OB-LGA) infants. LGA placentas were larger but showed no change in insulin/mTOR signaling or amino acid transport activity. GLP-1R protein was expressed in the MVM isolated from human placenta. GLP-1R activation stimulated protein kinase alpha (PKA), extracellular signal-regulated kinase-1 and-2 (ERK1/2), and mTOR pathways in PHT cells. Our results suggest elevated maternal GLP-1 may drive fetal overgrowth in obese pregnant women. We speculate that maternal GLP-1 acts as a novel regulator of fetal growth by promoting placental growth and function.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Obstetrics & Gynecology, Division of Reproductive Sciences, University of Colorado Anschutz Medical Campus, Aurora, CO, U.S.A.
- Section of Neonatology, Department of Pediatrics, University of Colorado Anschutz Medical Campus, Aurora, CO, U.S.A.
ORCID-Profile: Jerad H Dumolt
Förderung
- NICHD NIH HHS
Zitieren
APA
Dumolt, J. H., Rosario, F. J., Kramer, A. C., Horwitz, S., Powell, T. L., & Jansson, T. (2023). Maternal glucagon-like peptide-1 is positively associated with fetal growth in pregnancies complicated with obesity. Clinical Science, 137(8), 663-678. https://doi.org/10.1042/cs20220890
Vancouver
Dumolt JH, Rosario FJ, Kramer AC, Horwitz S, Powell TL, Jansson T. Maternal glucagon-like peptide-1 is positively associated with fetal growth in pregnancies complicated with obesity. Clinical Science. 2023;137(8):663-678. doi:10.1042/cs20220890
BibTeX
@article{Dumolt2023,
author = {Dumolt, Jerad H and Rosario, Fredrick J and Kramer, Avery C and Horwitz, Stacee and Powell, Theresa L and Jansson, Thomas},
title = {Maternal glucagon-like peptide-1 is positively associated with fetal growth in pregnancies complicated with obesity},
journal = {Clinical Science},
year = {2023},
volume = {137},
number = {8},
pages = {663--678},
doi = {10.1042/cs20220890}
}
EUVIMED